This co-culture environment appeared to enhance the metabolic and molecular interactions mediated by the FABP4/UCP2 axis pathway, contributing to the ability of CTX-DTP CRC cells to withstand the cytotoxic effects of cetuximab in Fig. 6B and C. Here, FABP4 is linked to colorectal carcinoma.